Ceapro Inc - stock earnings
CZO.V Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -1.0 million CAD | 2.6 million CAD |
2023Q2 | -1.2 million CAD | 1.9 million CAD |
2023Q1 | -385050 CAD | 3.5 million CAD |
2022Q4 | -122109 CAD | 3.3 million CAD |
2022Q3 | 861648 CAD | 3.8 million CAD |
2022Q2 | 1.7 million CAD | 5.5 million CAD |
2022Q1 | 2.0 million CAD | 6.2 million CAD |
2021Q4 | 775855 CAD | 3.6 million CAD |
2021Q3 | 875274 CAD | 4.5 million CAD |
2021Q2 | 676472 CAD | 4.4 million CAD |
2021Q1 | 514876 CAD | 4.7 million CAD |
2020Q4 | -538617 CAD | 2.7 million CAD |
2020Q3 | 191623 CAD | 3.5 million CAD |
2020Q2 | 1.1 million CAD | 4.7 million CAD |
2020Q1 | 1.1 million CAD | 4.3 million CAD |
2019Q4 | 166105 CAD | 3.7 million CAD |
2019Q3 | -103514 CAD | 2.9 million CAD |
2019Q2 | -558591 CAD | 3.1 million CAD |
2019Q1 | -636628 CAD | 3.2 million CAD |
2018Q4 | 444032 CAD | 4.5 million CAD |
2018Q3 | -298669 CAD | 2.1 million CAD |
2018Q2 | -165693 CAD | 2.7 million CAD |
2018Q1 | -295207 CAD | 2.3 million CAD |
2017Q4 | -1.6 million CAD | 3.0 million CAD |
2017Q3 | 295570 CAD | 3.6 million CAD |
2017Q2 | 370422 CAD | 3.2 million CAD |
2017Q1 | 17768 CAD | 3.2 million CAD |
2016Q4 | 125662 CAD | 2.4 million CAD |
CZO.V Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -2.8 million CAD | 11.3 million CAD |
2022 | 4.4 million CAD | 18.8 million CAD |
2021 | 2.8 million CAD | 17.2 million CAD |
2020 | 1.9 million CAD | 15.1 million CAD |
2019 | -1.1 million CAD | 12.9 million CAD |
2018 | -315537 CAD | 11.6 million CAD |
2017 | -958275 CAD | 12.9 million CAD |
2016 | 3.6 million CAD | 13.7 million CAD |
2015 | 4.9 million CAD | 10.7 million CAD |
2014 | 1.6 million CAD | 8.9 million CAD |
2013 | 175808 CAD | 6.5 million CAD |
CZO.V
Price: CA$0.24
52 week price:
Earnings Per Share: -0.03 CAD
P/E Ratio: -5.83
Exchange: VAN
Sector: Healthcare
Industry: Biotechnology
Volume: 26500
Market Capitalization: 19.2 million